Spire Healthcare Group (LON:SPI) Trading 13.8% Higher - Here's Why

Key Points

• Sspire Healthcare Group's shares rose by 13.8% to close at GBX 246.43 ($3.34) amid significantly increased trading volume of 42,338,680 shares.
• Analysts maintain a positive outlook, with a buy rating from Berenberg Bank and a revised price target between GBX 280 and GBX 303, reflecting confidence in the company's growth potential.
• The company reported an EPS of GBX 4.10 for the last quarter, with forecasts estimating a total of 15.66 EPS for the current year, indicating potential for earnings growth.

Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) traded up 13.8% on Friday . The stock traded as high as GBX 256.50 ($3.48) and last traded at GBX 246.43 ($3.34). 42,338,680 shares changed hands during trading, an increase of 2,469% from the average session volume of 1,648,148 shares. The stock had previously closed at GBX 216.50 ($2.93).

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Berenberg Bank restated a "buy" rating and set a GBX 280 price objective on shares of Spire Healthcare Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. dropped their price objective on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a research report on Tuesday, August 5th. Three analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has an average rating of "Buy" and an average price target of GBX 294.33.

Spire Healthcare Group Stock Up 14.1%

The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74. The stock has a market capitalization of £993.86 million, a P/E ratio of 5,369.57, a P/E/G ratio of 1.06 and a beta of 0.96. The firm has a 50-day simple moving average of GBX 218.25 and a 200 day simple moving average of GBX 203.40.

Spire Healthcare Group (LON:SPI - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, equities research analysts forecast that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.